Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carsten Riether

Showing results (51-60 of 73) with videos related to

Pageof 8
Sort By:
Frontiers in Immunology|October 10, 2022
Siglec-7 represents a glyco-immune checkpoint for non-exhausted effector memory CD8+ T cells with high functional and metabolic capacitiesQuentin Haas, Nikita Markov, Lukas Muerner, et al.
Molecular Cancer Therapeutics|May 5, 2017
The Multi-kinase Inhibitor Debio 0617B Reduces Maintenance and Self-renewal of Primary Human AML CD34<sup>+</sup> Stem/Progenitor CellsMaximilien Murone, Ramin Radpour, Antoine Attinger, et al.
Cell Death and Differentiation|December 18, 2019
ATG12 deficiency leads to tumor cell oncosis owing to diminished mitochondrial biogenesis and reduced cellular bioenergeticsHe Liu, Zhaoyue He, Nina Germič, et al.
Leukemia|September 26, 2022
Splenic red pulp macrophages provide a niche for CML stem cells and induce therapy resistanceElias D Bührer, Michael A Amrein, Stefan Forster, et al.
Nature Communications|April 4, 2020
TNIK signaling imprints CD8<sup>+</sup> T cell memory formation early after primingCarla A Jaeger-Ruckstuhl, Magdalena Hinterbrandner, Sabine Höpner, et al.
Frontiers in Immunology|June 4, 2019
Targeting Mutated Plus Germline Epitopes Confers Pre-clinical Efficacy of an Instantly Formulated Cancer Nano-VaccineMona O Mohsen, Monique Vogel, Carsten Riether, et al.
Blood|January 27, 2026
High-Dimensional Spatiotemporal Single-Cell Atlas and 3D imaging of Bone Marrow Microenvironment during CML ProgressionLanzhu Li, Isabelle Rottmann, Borhan R Saeed, et al.
Haematologica|February 13, 2023
Results from a phase I/II trial of cusatuzumab combined with azacitidine in patients with newly diagnosed acute myeloid leukemia who are ineligible for intensive chemotherapyThomas Pabst, Norbert Vey, Lionel Adès, et al.
Oncogene|September 2, 2018
mTOR mediates a mechanism of resistance to chemotherapy and defines a rational combination strategy to treat KRAS-mutant lung cancerShun-Qing Liang, Elias D Bührer, Sabina Berezowska, et al.
The Journal of Clinical Investigation|May 27, 2015
IL-33 signaling contributes to the pathogenesis of myeloproliferative neoplasmsLukas F Mager, Carsten Riether, Christian M Schürch, et al.
Pageof 8

Showing results (51-60 of 73) with videos related to

Sort By:
Pageof 8
Frontiers in Immunology|October 10, 2022
Siglec-7 represents a glyco-immune checkpoint for non-exhausted effector memory CD8+ T cells with high functional and metabolic capacitiesQuentin Haas, Nikita Markov, Lukas Muerner, et al.
Molecular Cancer Therapeutics|May 5, 2017
The Multi-kinase Inhibitor Debio 0617B Reduces Maintenance and Self-renewal of Primary Human AML CD34<sup>+</sup> Stem/Progenitor CellsMaximilien Murone, Ramin Radpour, Antoine Attinger, et al.
Cell Death and Differentiation|December 18, 2019
ATG12 deficiency leads to tumor cell oncosis owing to diminished mitochondrial biogenesis and reduced cellular bioenergeticsHe Liu, Zhaoyue He, Nina Germič, et al.
Leukemia|September 26, 2022
Splenic red pulp macrophages provide a niche for CML stem cells and induce therapy resistanceElias D Bührer, Michael A Amrein, Stefan Forster, et al.
Nature Communications|April 4, 2020
TNIK signaling imprints CD8<sup>+</sup> T cell memory formation early after primingCarla A Jaeger-Ruckstuhl, Magdalena Hinterbrandner, Sabine Höpner, et al.
Frontiers in Immunology|June 4, 2019
Targeting Mutated Plus Germline Epitopes Confers Pre-clinical Efficacy of an Instantly Formulated Cancer Nano-VaccineMona O Mohsen, Monique Vogel, Carsten Riether, et al.
Blood|January 27, 2026
High-Dimensional Spatiotemporal Single-Cell Atlas and 3D imaging of Bone Marrow Microenvironment during CML ProgressionLanzhu Li, Isabelle Rottmann, Borhan R Saeed, et al.
Haematologica|February 13, 2023
Results from a phase I/II trial of cusatuzumab combined with azacitidine in patients with newly diagnosed acute myeloid leukemia who are ineligible for intensive chemotherapyThomas Pabst, Norbert Vey, Lionel Adès, et al.
Oncogene|September 2, 2018
mTOR mediates a mechanism of resistance to chemotherapy and defines a rational combination strategy to treat KRAS-mutant lung cancerShun-Qing Liang, Elias D Bührer, Sabina Berezowska, et al.
The Journal of Clinical Investigation|May 27, 2015
IL-33 signaling contributes to the pathogenesis of myeloproliferative neoplasmsLukas F Mager, Carsten Riether, Christian M Schürch, et al.
Pageof 8